Literature DB >> 19777320

Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET.

Orla Buckley1, Leona Doyle, Robert Padera, Neal Lakdawala, Sharmila Dorbala, Marcelo Di Carli, Raymond Kwong, Akshay Desai, Ron Blankstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19777320      PMCID： PMC3954521          DOI： 10.1007/s12350-009-9145-2

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  6 in total

1.  Cardiac sarcoidosis: spectrum of MRI features.

Authors:  Olivier Vignaux
Journal:  AJR Am J Roentgenol       Date:  2005-01       Impact factor: 3.959

2.  The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis.

Authors:  Jan-Peter Smedema; Gabriel Snoep; Marinus P G van Kroonenburgh; Robert-Jan van Geuns; Emiel C Cheriex; Anton P M Gorgels; Harry J G M Crijns
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

3.  Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.

Authors:  Wataru Okumura; Tsutomu Iwasaki; Takuji Toyama; Tatsuya Iso; Masashi Arai; Noboru Oriuchi; Keigo Endo; Tomoyuki Yokoyama; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  J Nucl Med       Date:  2004-12       Impact factor: 10.057

Review 4.  Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.

Authors:  M Sekiguchi; Y Yazaki; M Isobe; M Hiroe
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

5.  Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.

Authors:  Hiroyuki Yamagishi; Naoya Shirai; Masahiko Takagi; Minoru Yoshiyama; Kaname Akioka; Kazuhide Takeuchi; Junichi Yoshikawa
Journal:  J Nucl Med       Date:  2003-07       Impact factor: 10.057

6.  Clinicopathological study of fatal myocardial sarcoidosis.

Authors:  Y Matsui; K Iwai; T Tachibana; T Fruie; N Shigematsu; T Izumi; A H Homma; R Mikami; O Hongo; Y Hiraga; M Yamamoto
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691
  6 in total
  5 in total

Review 1.  Dilated cardiomyopathy with conduction disease and arrhythmia.

Authors:  Neal K Lakdawala; Michael M Givertz
Journal:  Circulation       Date:  2010-08-03       Impact factor: 29.690

2.  Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation.

Authors:  Michael Osborne; Swathy Kolli; Robert F Padera; Masanao Naya; Eldrin Lewis; Sharmila Dorbala; Marcelo F Di Carli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2013-04       Impact factor: 5.952

3.  The logic and challenges of imaging sarcoidosis with whole body FDG PET.

Authors:  Roberto C Valentin; Pradeep Bhambhvani
Journal:  J Nucl Cardiol       Date:  2017-08-17       Impact factor: 5.952

4.  Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis.

Authors:  Tomas Vita; David R Okada; Mahdi Veillet-Chowdhury; Paco E Bravo; Erin Mullins; Edward Hulten; Mukta Agrawal; Rachna Madan; Viviany R Taqueti; Michael Steigner; Hicham Skali; Raymond Y Kwong; Garrick C Stewart; Sharmila Dorbala; Marcelo F Di Carli; Ron Blankstein
Journal:  Circ Cardiovasc Imaging       Date:  2018-01       Impact factor: 7.792

5.  Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis.

Authors:  Michael Soussan; Pierre-Yves Brillet; Hilario Nunes; Gabriel Pop; Matthieu-John Ouvrier; Nicolas Naggara; Dominique Valeyre; Pierre Weinmann
Journal:  J Nucl Cardiol       Date:  2012-11-28       Impact factor: 5.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.